Psychedelics approved for medical use
16 Jun 2023
The Therapeutic Goods Administration (TGA) will classify psilocybin and methylenedioxymethamphetamine (MDMA) as Schedule 8 drugs, effective 1 July 2023.
Clinical use will be restricted to the treatment of two conditions:
- psilocybin for treatment-resistant depression
- MDMA for treatment-resistant PTSD.
The only practitioners who will be able to prescribe the drugs are psychiatrists who:
- have obtained approval from a human research ethics committee (HREC) that is registered with the National Health and Medical Research Council (NHMRC)
- are specifically authorised under the TGA’s Authorised Prescriber scheme
- supervise their patients when they take the medicine, in a health facility.
Requirements for authorisation are expected to be made available by the TGA before 1 July 2023.
Psychiatrists will need to check whether their State or Territory government adopts the amendments to the Poisons Standard in their entirety.
Australia is one of the first countries to recognise psychedelics as medicines. There are still unknowns about safety and efficacy, treatment protocols (including how to treat relapses), and training. The Royal Australian and New Zealand College of Psychiatrists (RANZCP) has produced some resources and plans to develop further guidance for psychiatrists.
The substances will remain Schedule 9 for all other indications, meaning they are restricted for use in clinical trials.
For further information see:
- TGA announcement and Q&A’s
- RANZCP Therapeutic use of psychedelic substances and webinar Psychedelic-assisted therapy: what psychiatrists need to know
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Doctors Let's Talk: Get Yourself A Fricking GP
Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.
25 Oct 2022
Systematic efforts to reduce harms due to prescribed opioids – webinar recording
Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme.
14 May 2021
Diplomacy in a hierarchy: tips for approaching a difficult conversation
Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.
05 Oct 2020
